Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) - Join Clinical Trial NCTNCT03297606
How to Join This Clinical Trial - NCTNCT03297606
Learn how to participate in this PHASE2 trial studying an investigational therapy for Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT03297606 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 10 locations. Find a study site near you:
Clinical Research Site
Edmonton, Alberta T6G 1Z2 - Canada
Status: RECRUITING
Clinical Research Site
Kelowna, British Columbia V1Y 5L3 - Canada
Status: RECRUITING
Clinical Research Site
Vancouver, British Columbia V5Z 4E6 - Canada
Status: RECRUITING
Clinical Research Site
Kingston, Ontario K7L 2V7 - Canada
Status: RECRUITING
Clinical Research Site
London, Ontario N6A 5W9 - Canada
Status: RECRUITING
Clinical Research Site
Ottawa, Ontario K1H 8L6 - Canada
Status: RECRUITING
Clinical Research Site
Toronto, Ontario M5G 2M9 - Canada
Status: RECRUITING
Clinical Research Site
Montreal, Quebec H3T 1E2 - Canada
Status: RECRUITING
Clinical Research Site
Regina, Saskatchewan S4T 7T1 - Canada
Status: RECRUITING
Clinical Research Site
Saskatoon, Saskatchewan S7N 4H4 - Canada
Status: RECRUITING
How to Enroll in This Study
To learn more about participating in this PHASE2 clinical trial for Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships